Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Tirzepatide is a clinician-prescribed dual incretin receptor agonist designed to support appetite regulation and metabolic function via GLP-1 and GIP activity
At the time of acquisition, Sequence had 24,000 members, and WW has around 3.5M users
These agents include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)
(U.S.) Boehringer Ingelheim International GmbH (Germany) Merck & Co., Inc
US$ 22.61
US$ 27.91
US$ 25.76
US$ 20.72
US$ 21.58
US$ 29.87
US$ 29.87
US$ 20.81
US$ 26.95
